Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Long-Term Debt Repayments (2018 - 2024)

Mimedx's Long-Term Debt Repayments history spans 4 years, with the latest figure at $30.0 million for Q1 2024.

  • For Q1 2024, Long-Term Debt Repayments changed N/A year-over-year to $30.0 million; the TTM value through Dec 2024 reached $30.0 million, changed N/A, while the annual FY2024 figure was $30.0 million, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q1 2024 was $30.0 million at Mimedx, up from $1000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $30.0 million in Q1 2024 and bottomed at $30.0 million in Q1 2024.